Table 1.
Outcomes, demographic characteristics and co‐existing conditions for SARS‐CoV‐2 infections among adults with HIV in the Western Cape, stratified by age group (percentages and counts).
| Cases until end of wave 3 | All cases (including wave 4) | |||
|---|---|---|---|---|
| Characteristic/outcome |
Ages 15–39 years n = 9321 |
Ages ≥40 years n = 8799 |
All ages n = 18,120 |
All ages n = 22,057 |
| Death | 2.9 (270) | 8.6 (757) | 5.7 (1027) | 5.6 (1233) |
| Sex | ||||
| Female | 77.8 (7249) | 63.8 (5610) | 71.0 (12,859) | 70.5 (15,561) |
| Male | 22.2 (2072) | 36.2 (3189) | 29.0 (5261) | 29.5 (6496) |
| Age (years) | ||||
| 15–24 | 9.6 (895) | − | 4.9 (895) | 5.0 (1106) |
| 25–29 | 21.6 (2011) | − | 11.1 (2011) | 11.4 (2517) |
| 30–34 | 32.8 (3057) | − | 16.9 (3057) | 17.4 (3841) |
| 35–39 | 36.0 (3358) | − | 18.5 (3358) | 18.7 (4130) |
| 40–49 | − | 60.1 (5286) | 29.2 (5286) | 28.6 (6308) |
| 50–59 | − | 29.4 (2590) | 14.3 (2590) | 13.9 (3057) |
| 60–69 | − | 8.2 (722) | 4.0 (722) | 3.9 (864) |
| ≥ 70 | − | 2.3 (201) | 1.1 (201) | 1.1 (234) |
| Hypertension | 8.7 (809) | 33.1 (2914) | 20.5 (3723) | 19.8 (4360) |
| Diabetes | 4.0 (369) | 15.8 (1391) | 9.7 (1760) | 9.1 (1999) |
| Chronic obstructive pulmonary disease | 4.1 (379) | 10.4 (917) | 7.2 (1296) | 7.8 (1714) |
| Chronic kidney disease | 0.9 (86) | 6.6 (584) | 3.7 (670) | 3.6 (784) |
| Tuberculosis a (years since) | ||||
| Absent | 73.3 (6830) | 66.7 (5868) | 70.1 (12,698) | 68.3 (15,068) |
| ≥ 1 | 18.0 (1674) | 26.4 (2323) | 22.1 (3997) | 22.3 (4911) |
| < 1 | 3.6 (338) | 2.7 (238) | 3.2 (576) | 3.7 (806) |
| Ongoing | 5.1 (479) | 4.2 (370) | 4.7 (849) | 5.8 (1272) |
| Pregnancy (in women aged 15–49 years) | 10.8 (784) | 1.4 (50) | 7.7 (834) | 7.8 (1028) |
| Number of previous SARS‐CoV‐2 diagnoses | ||||
| 0 | 98.1 (9146) | 98.6 (8675) | 98.3 (17,821) | 96.6 (21,316) |
| 1 | 1.9 (173) | 1.4 (121) | 1.6 (294) | 3.3 (722) |
| 2 | 0.0 (2) | 0.0 (3) | 0.0 (5) | 0.1 (19) |
| Number of conditions b | ||||
| 0 | 62.4 (5814) | 36.0 (3169) | 49.6 (8983) | 48.7 (10,746) |
| 1 | 31.7 (2957) | 38.3 (3368) | 34.9 (6325) | 35.7 (7872) |
| 2 | 5.1 (476) | 17.9 (1572) | 11.3 (2048) | 11.5 (2533) |
| ≥3 | 0.8 (74) | 7.8 (690) | 4.2 (764) | 4.1 (906) |
a
Time since the most recent evidence of a start of an episode; with episodes beginning after 2 months before the SARS‐CoV‐2 diagnosis considered as ongoing.
b
Hypertension, diabetes, chronic obstructive pulmonary disease, chronic kidney disease and tuberculosis (at any time).